Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19.
“I’m feeling well and symptom free,” Bourla said in a statement.
Bourla, who received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech, tested positive for COVID just 6 weeks ago.
The 60-year-old CEO had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid. The antiviral medication is claimed to treat high-risk people, such as older patients.
Bourla said he has not yet taken the new bivalent booster because he is “following CDC guidelines to wait three months since my previous COVID case…”
A federal health agency said this week that over 25 million doses of the so-called bivalent shots had been sent out. That consisted of mostly the Pfizer/BioNTech vaccine, as production of the Moderna vaccine ramps up.
The production ramp up hasn’t matched the demand for the bivalent shot. Just less than 2% of US adults have gotten the updated COVID booster.
(Source: Reuters)
